Phenylboronic Acid

Phenylboronic Acid

SCHEMBL18192028

OB(O)c1ccccc1.c1ccc(-c2ccccc2-n2cnc3ccccc32)cc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR1 Q9BXC0 1/20 0.47
HTT P42858 3/20 0.46
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
FGFR1 P11362 2/20 0.42
POLB P06746 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
PTK2B Q14289 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
ENPP2 Q13822 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27995809 0.89 HTT (0.58) HCAR1HTTKDM4EHPGDFGFR1
SCHEMBL26085163 0.80 HTT (0.51) HCAR1HTTKDM4EHPGDFGFR1
Phenylboronic Acid SCHEMBL18192012 0.80 HTT (0.74) HTTFGFR1
SCHEMBL23266636 0.79 HTT (0.60) HTTFGFR1POLBALDH1A1
SCHEMBL5791820 0.78 CYP17A1 (0.50) HCAR1HTTFGFR1POLBALDH1A1
SCHEMBL366895 0.77 HTT (0.47) HCAR1HTTKDM4EHPGDFGFR1
SCHEMBL24179389 0.76 HTT (0.50) HCAR1HTTKDM4EHPGDFGFR1
SCHEMBL23266691 0.76 HTT (0.53) HCAR1HTTKDM4EFGFR1POLB
SCHEMBL8623648 0.75 HTT (0.51) HTTFGFR1POLBALDH1A1MAPK1
SCHEMBL17602704 0.75 FGFR1 (0.68) HTTKDM4EFGFR1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3088392-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MAT LTD (KR) 2020-03-11 EP disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 HCAR1 3869/4885HTT 2080/4885KDM4E 1977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.